SCHEMBL18708494

SCHEMBL18708494

O=C(O)c1ccc(-c2nnc(-c3ccc(-n4cccn4)cc3)o2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.61
▸ RAB9A P51151 4/20 0.61
▸ KMT2A Q03164 1/20 0.51
▸ LMNA P02545 1/20 0.48
▸ MGLL Q99685 1/20 0.47
▸ KDM5A P29375 1/20 0.47
▸ KDM2B Q8NHM5 1/20 0.47
▸ KDM4C Q9H3R0 1/20 0.47
▸ KDM5B Q9UGL1 1/20 0.47
▸ MYC P01106 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ NR1H4 Q96RI1 1/20 0.45
▸ MAPK14 Q16539 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ RARA P10276 1/20 0.43
▸ RARB P10826 1/20 0.43
▸ RARG P13631 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18708489 0.89 MYC (0.53) NPC1RAB9AKMT2AMGLLKDM5A
SCHEMBL321724 0.85 LMNA (0.61) LMNAMGLLKDM5AKDM2BKDM4C
SCHEMBL1675470 0.79 HDAC6 (0.51) KDM5AKDM2BKDM4CKDM5BHDAC6
SCHEMBL11438341 0.79 NPC1 (0.89) NPC1RAB9AKMT2AMYCHDAC6
SCHEMBL12171532 0.78 RAB9A (0.57) NPC1RAB9AKMT2AMYCHDAC6
SCHEMBL4883318 0.77 NPC1 (1.00) NPC1RAB9AKMT2AMYCHDAC6
SCHEMBL12171414 0.76 NPC1 (0.96) NPC1RAB9AKMT2AMYCHDAC6
SCHEMBL12170932 0.75 NPC1 (0.74) NPC1RAB9AKMT2AMYCHDAC6
SCHEMBL17303476 0.74 NOTUM (0.58) KMT2ALMNAMGLLKDM4EALDH1A1
SCHEMBL2401139 0.73 NOTUM (0.53) NPC1RAB9AKMT2ALMNAMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611230-B2 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease PTC THERAPEUTICS, INC. (US) 2017-04-04 — — US disclosed
Send feedback